EMA Gets Specific On Pharmacovigilance Of Drugs Used In Pregnancy

Draft Guideline Issued After Three Year Delay

A new EU guideline offers recommendations for facilitating appropriate pharmacovigilance for drugs that may be used in pregnant or breastfeeding women.

Belly of pregnant woman and vitamin pills in the hand.,Close-up.
EU Explains Safety Considerations For Drugs Used In Pregnancy/Breastfeeding • Source: Shutterstock

The European Medicines Agency has issued a much-awaited draft guideline on pharmacovigilance requirements specifically for medicines that may be used during pregnancy and breastfeeding.

Among other things, manufacturers are told that relevant knowledge gaps regarding risks associated with a drug that is expected to...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography